Trial intelligence / Profile preview

RD14-01 in advanced solid tumors

NCT05748938Phase 2Unknown

Start
Feb 2023
Primary completion
Aug 2024
Modality
CAR-T Cells
Countries
1
01

Overview

A Phase 2 trial of RD14-01 in solid tumor. Status: unknown.

02

Drugs

RD14-01
03

Conditions

solid tumor

Beyond the preview

Go deeper on NCT05748938.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05748938.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call